Daily Judi

Daily Judi: Tuesday, March 19, 2023

Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

Annika Kim Constantino reports that U.S. Food and Drug Administration staff said Biogen’s new ALS drug, BIIB067, may have a “clinical benefit” on an aggressive and rare form of ALS. The FDA is scheduled to decide on approval for the drug on April 25. (CNBC)

On the Applied Clinical Trials Podcast, Rose Blackburne, MD, MBA, and Margarita Nunez, MD, discuss their recent panel at the Health Equity in Clinical Trials Congress in Boston.

After a report indicated a steep decline in clinical trials, Marc Bailey, Chief Science and Innovation Officer at the Medicines and Healthcare products Regulatory Agency in Britain, announced new measures to speed approvals and make clinical trials easier to conduct in the United Kingdom. (Reuters)


Our Culture

“Technology and process improvements will continue to decrease our timelines on creating specifications by 50 percent or more, this year. The more we continue to improve the faster we will be.”

   –Jamie, Trial Delivery



About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 133,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.

No tags found.

Stay up-to-date with whats happening

Some sub copy covering what weekly/monthly update sand news one can expect.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.